FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to an immunomodulatory composition for injection into a mammal. The immunomodulatory composition for injection into a mammal containing a hydrolysate prepared by acid and/or enzymatic hydrolysis of one or more bioresources specified in a group consisting of bivalve molluscs, annelids, leeches, and water taken in certain proportions. A method for preparing the immunomodulatory composition for injection into a mammal. A method of treating a pathological condition in a mammal in need thereof involving the injections of the immunomodulatory composition into the above mammal. Using the composition for normalising metabolism into the mammal in need thereof.
EFFECT: composition enables extending the range of products with immunomodulatory activity for injections.
19 cl, 7 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BASED ON BIORESOURCES COMPOSITIONS FOR PREVENTION OR TREATMENT OF SEPSIS AND/OR SEPSIS-RELATED COMPLICATIONS AND CONDITIONS, METHODS FOR SEPSIS PREVENTION AND TREATMENT | 2015 |
|
RU2622745C2 |
| NEW INJECTABLE COMPOSITIONS OF EPRINOMECTIN | 2011 |
|
RU2578036C2 |
| INJECTION ANTIBACTERIAL PHARMACEUTICAL COMPOSITION | 2014 |
|
RU2563826C1 |
| COMPOSITIONS OF LONG-TERM ACTION BASED ON KETOPROFEN | 2014 |
|
RU2646829C1 |
| WAYS AND COMPOSITIONS FOR ADIPOSITY TREATMENT, INSULIN-DEPENDENT DISEASES AND HYPERCHOLESTERINEMIA | 2005 |
|
RU2359689C2 |
| SPASMOLYTIC COMPOSITION, METHOD TO OBTAIN SPASMOLYTIC COMPOSITION | 1997 |
|
RU2182016C2 |
| COMPOSITION CONTAINING PROTEIN MATERIAL AND COMPOUNDS WHICH CONTAIN UNOXIDISABLE STRUCTURAL ELEMENTS OF FATTY ACIDS | 2005 |
|
RU2394598C2 |
| COMPOSITION GLP-1 FOR TREATING OBESITY AND WEIGHT CONTROL | 2019 |
|
RU2834226C2 |
| METHOD FOR TREATING PATIENTS FOR NEOPLASMS | 2005 |
|
RU2275920C1 |
| FULVESTRANT COMPOSITIONS | 2018 |
|
RU2684330C1 |
